We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

COL:ASXColes Group Ltd. Analysis

Data as of 2026-05-25 - not real-time

A$21.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Coles Group Limited is trading at AUD 21.33, well above its DCF fair value of AUD 7.27, implying limited upside despite a modest 8.9% upside/downside metric. The stock sits below its 20‑day (21.66), 50‑day (21.95) and 200‑day (22.11) moving averages, volume is on a decreasing trend, and the RSI of 44 suggests neutral‑to‑bearish momentum, all pointing to short‑term pressure. Meanwhile, the company delivers a solid 3.42% dividend yield but with a high payout ratio of about 91%, raising questions about dividend sustainability amid a debt‑to‑equity ratio exceeding 270%. Fundamentals show modest revenue growth (2.5%), thin operating margins (3.9%), and a high PE of 28, reinforcing a value‑oriented profile rather than growth. The sector – Consumer Defensive – is traditionally low‑risk, yet regulatory scrutiny on grocery pricing and competition with Woolworths adds medium‑level regulatory risk. Overall, the market sentiment is in “Extreme Greed” territory (fear‑greed index 91.68), which may be inflating the price beyond intrinsic levels.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages and decreasing volume
  • Valuation far above DCF fair value
  • Bearish technical momentum (RSI, MACD histogram)

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable cash flow and attractive dividend yield
  • Defensive consumer sector providing earnings resilience
  • High debt level and elevated payout ratio limiting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental strengths in ROE and cash generation
  • Potential price correction aligning with intrinsic value
  • Ongoing competitive pressure and regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth2.50%
Profit Margin2.25%
P/E Ratio28.1
ROE26.52%
ROA5.64%
Debt/Equity272.26
P/B Ratio7.3
Op. Cash FlowA$3.1B
Free Cash FlowA$1.4B

Technical Analysis

TrendBearish
RSI43.9
SupportA$20.32
ResistanceA$23.14
MA 20A$21.66
MA 50A$21.95
MA 200A$22.11
MACDBullish
VolumeDecreasing
Fear & Greed Index91.68

Valuation

Fair ValueA$7.27
Target PriceA$23.24
Upside/Downside8.98%
GradeOvervalued
TypeValue
Dividend Yield3.42%

Risk Assessment

Beta-0.01
Volatility24.56%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.